SENSEX NIFTY

Us Drug Regulator

Jan 20, 2017 at 16:46 | Source: Reuters
The head of the International Monetary Fund said on Friday that one of the biggest risks to the global economy in 2017 was "a race to the bottom" on taxes, regulations and trade, in an indirect reference to the policy plans of the incoming US administration.
Jan 20, 2017 at 15:58 | Source: PTI
Shanghai, Jan 20 (AFP) China's state-owned chemicalcorporation ChemChina has asked US anti-trust regulators togreenlight its USD 43 billion acquisition of Swiss seed giantSyngenta, a report said today.
Jan 19, 2017 at 14:03 | Source: CNBC-TV18
The company Wednesday received the US Food and Drug Administration (USFDA) approval for an anti-migraine drug for which it had filed the Abbreviated New Drug Application (ANDA) in 2012.
Jan 19, 2017 at 12:33 | Source: Moneycontrol.com
The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
Jan 18, 2017 at 16:44 | Source: PTI
Drug firm Zydus Cadila today said it has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in the American market.
Jan 18, 2017 at 10:07 | Source: Moneycontrol.com
US FDA gave a clearance to the company's drug Rizatripan Bonzoate tablet, which is used to treat symptoms due to migraine.
Jan 17, 2017 at 18:24 | Source: CNBC
The three-pronged catalyst of lower taxes, less regulation and more domestic spending could push gross domestic product well above the trend of the past eight years, the noted author said.
Jan 14, 2017 at 14:00 | Source: Moneycontrol.com
Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years
Jan 13, 2017 at 12:44 | Source: PTI
The company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from the US Food and Drug Administration (USFDA).
Jan 13, 2017 at 12:30 | Source: Moneycontrol.com
The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Drug Administration (USFDA).
Messages on Us Drug Regulator »

BSE/NSE Announcer

Platinum Member

20357 Followers

Wockhardt  

With reference to news appeared in Business Standard dated January 04, 2017 quoting "US drug regulator issues warning to Wockhardts Ankleshwar plant", Wockhardt Ltd has submitted to BSE a copy of Clarification is enclosed.

1.18 PM Jan 4th

BSE/NSE Announcer

Platinum Member

20357 Followers

Wockhardt  

The Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "US drug regulator issues warning to Wockhardts Ankleshwar plant.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including

11.11 AM Jan 4th

BSE/NSE Announcer

Platinum Member

20357 Followers

Wockhardt  

The Exchange has sought clarification from Wockhardt Ltd on January 04, 2017 with reference to news appeared in Business Standard dated January 04, 2017 quoting "US drug regulator issues warning to Wockhardts Ankleshwar plant".The reply is awaited.

10.29 AM Jan 4th

kalpataru70

Platinum Member

497 Followers

Aurobindo Pharm  

the development, a company official said they had received a minor observation from the US drug regulator in the month of October and it was not going to have any material impact going forward. Earlier in February, Aurobindo`s Unit VII in Mahaboobnagar district in Telangana received some Form 483 observations

10.21 PM Dec 21st 2016

porfavor

New Member

2 Followers

Sun Pharma  

drug used to treat dry eye disease. The drug is currently undergoing late stage clinical trials (phase III) and about 16 million people in the US itself are believed to have been suffering from dry eye disease.Currently there are two drugs approved by the US drug regulator for this condition. Allergan

1.12 PM Dec 1st 2016

sanvad2016

New Member

0 Follower

Sun Pharma  

Sun Pharma: The US drug regulator has found seven breaches of manufacturing standards at Sun Pharmaceutical Industries Ltd’s formulations plant in Mohali, Punjab, following a recent inspection.

10.07 AM Nov 25th 2016

premiumstoc
ktips

New Member

100 Followers

Alkem Lab  

alkem laboratories has dipped 8% to rs 1,655 on the bse in early morning trade after the pharmaceuticals company said it has received 13 observations from the us drug regulator for its manufacturing facility at daman;

11.09 AM Sep 30th 2016

premiumstoc
ktips

New Member

100 Followers

Marksans Pharma  

Marksans Pharma moved higher by 11% on the BSE after the company announced that it has got US drug regulator nod for loratadine liquid filed capsules 10 mg.

5.11 PM Sep 26th 2016

SaintEquity

Platinum Member

341 Followers

SBI  

Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs. 53.85 after the company announced that it has received US drug regulator`s approval for a medicine used in treatment of sneezing, runny nose and other allergies.

11.42 AM Sep 26th 2016

nakhan_pat

Platinum Member

644 Followers

Cadila Health  

Cadila health - Gujrat based oral solid dosage drug manufacturing plant received establishment inspection from US Drug Regulator.

12.53 PM Sep 2nd 2016

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.